Impact of Mechanical
and Biological Aortic Valve Replacement on Coronary Perfusion: A Prospective,
Randomized Study
Farhad Bakhtiary, Nasreddin Abolmaali,
Omer Dzemali, Thomas Wittlinger, Mirko Doss, Anton Moritz, Peter Kleine
Departments of Thoracic and Cardiovascular
Surgery and Diagnostic and Interventional Radiology, Johann Wolfgang
Goethe University Hospital, Frankfurt/Main, Germany |
Background and aim of the study: Coronary perfusion is
impaired in patients with aortic stenosis (AS). Aortic valve replacement
(AVR) leads to improvement, but not complete restoration, of coronary
flow. Previous studies have shown that postoperative coronary flow rate
and coronary reserve in mechanical valves is dependent on valve design
and orientation. The study aim was to investigate acute changes in coronary
perfusion in patients undergoing mechanical or biological valve replacement
in a prospective, randomized clinical study.
Methods: Forty patients undergoing AVR for AS underwent MRI scanning to
measure coronary flow preoperatively and at five days after surgery. Patients
scheduled for mechanical AVR (n = 20) were randomized to a tilting disc
(Medtronic Hall) or bileaflet (Medtronic ADVANTAGE) prosthesis; the biological-valve
group (n = 20) received a stented (Medtronic Mosaic) or stentless (Medtronic
Freestyle) valve. Valve sizes were comparable in all groups. Patients also
underwent echocardiography both preoperatively and postoperatively to measure
transvalvular pressure gradients. The rate-pressure product (RPP) was calculated
as a marker of |
myocardial oxygen demand and cardiac workload.
Results: The mean preoperative coronary flow rate was 90 ± 32 ml/min,
and this increased after AVR in all patients. The rise in the mechanical-valve
groups was comparable for the two tested valves, whereas in the biological-valve
groups a significantly higher increase for stentless valves was present
(p <0.05). Mean pressure gradients for the Hall and ADVANTAGE valves
were equal; for biological valves, the Mosaic demonstrated a higher mean
gradient (19 ± 6 mmHg) than the Freestyle (10 ± 4 mmHg) (p <0.05).
The RPP was lower for ADVANTAGE (mechanical group) and for Freestyle valves
(biological group).
Conclusion: Coronary artery flow was increased following AVR in all valve
groups. The rise was significantly more distinct for Medtronic Freestyle
stentless valves compared to the three other valve substitutes. As the
stentless design also demonstrated superior hemodynamics and a lower myocardial
oxygen demand with lower pressure gradients and lower RPP, this may have
a positive impact on the clinical long-term outcome of this valve.
The Journal of Heart Valve Disease 2006;15:5-11 |